Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
RGT-419B
i
Other names:
RGT-419B, RGT 419B, RGT419B, GDC-4198
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Regor, Roche
Drug class:
CDK2/4/6 inhibitor
Related drugs:
‹
TQB3616 (2)
PF-06873600 (1)
PF-07224826 (0)
SYH2043 (0)
NUV-422 (0)
TQB3616 (2)
PF-06873600 (1)
PF-07224826 (0)
SYH2043 (0)
NUV-422 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
CCNE1 overexpression
Estrogen Receptor Positive Breast Cancer
CCNE1 overexpression
Estrogen Receptor Positive Breast Cancer
RGT-419B
Sensitive: D – Preclinical
RGT-419B
Sensitive
:
D
RGT-419B
Sensitive: D – Preclinical
RGT-419B
Sensitive
:
D
ER positive
Estrogen Receptor Positive Breast Cancer
ER positive
Estrogen Receptor Positive Breast Cancer
RGT-419B
Sensitive: D – Preclinical
RGT-419B
Sensitive
:
D
RGT-419B
Sensitive: D – Preclinical
RGT-419B
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.